Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer

We examined a large dataset of female metastatic breast cancers (MBCs) profiled with comprehensive genomic profiling (CGP) to identify the prevalence and distribution of immunotherapy responsiveness‐associated biomarkers. DNA was extracted from 3831 consecutive MBCs: 1237 (ER(pos)/HER2 (neg)), 1953...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Sivapiragasam, Abirami, Ashok Kumar, Prashanth, Sokol, Ethan S., Albacker, Lee A., Killian, Jonathan K., Ramkissoon, Shakti H., Huang, Richard S. P., Severson, Eric A., Brown, Charlotte A., Danziger, Natalie, McGregor, Kimberly, Ross, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826457/
https://ncbi.nlm.nih.gov/pubmed/33314633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3550
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados